Table 1.
HF (N=156,743) | No HF (N=3,414,122) | |
---|---|---|
Demographics | ||
Age (years) | 68 ± 11 | 59 ± 14 |
Gender (% male) | 98 | 93 |
Race (% black) | 16 | 17 |
Marital Status | ||
Married (%) | 54 | 56 |
Single | 7 | 11 |
Divorced | 26 | 26 |
Widowed | 13 | 7 |
Income ($) | 19,859 (11,225–31,460) | 23,129 (11,752–36,490) |
Service connection (%) | 36 | 40 |
Medication use (%) | ||
Statin | 68 | 53 |
ACEI/ARB | 87 | 50 |
Beta blocker | 84 | 42 |
CCB | 44 | 31 |
Vasodilator | 14 | 4 |
Thiazide | 33 | 32 |
Loop diuretic | 79 | 16 |
Potassium sparing diuretic | 32 | 8 |
Anticoagulation | 37 | 17 |
Antiplatelet agents | 16 | 9 |
Digoxin | 35 | 4 |
Inotropic agent | 3 | 0 |
Comorbidities (%) | ||
Medication compliance | 89 | 94 |
Hypertension | 82 | 58 |
Diabetes Mellitus | 45 | 23 |
CVD | 42 | 10 |
CVA | 15 | 6 |
PAD | 16 | 5 |
Chronic lung disease | 43 | 17 |
Dementia | 2 | 1 |
Rheumatologic disease | 2 | 1 |
Liver disease | 2 | 1 |
Malignancy | 16 | 10 |
HIV | 0 | 1 |
Depression | 9 | 9 |
Vital signs | ||
SBP (mmHg) | 129±15 | 133±14 |
DBP (mmHg) | 71±9 | 76±9 |
BMI (kg/m2) | 30.4±7.2 | 29.1±5.6 |
Laboratory Findings | ||
eGFR (ml/min/1.73m2) | 78±14 | 84±16 |
Serum BNP (ng/l) | 262 (84–728) | 15 (1–74) |
Serum Cholesterol (mg/dl) | 163±38 | 183±38 |
Serum Sodium (mmol/l) | 139±3 | 139±3 |
Serum Potassium (mmol/l) | 4.3±0.3 | 4.3±0.4 |
Serum Bicarbonate (mmol/l) | 28±3 | 28±3 |
Serum BUN (mg/dl) | 19±8 | 15±5 |
Data presented as mean ± standard deviation or median and interquartile range. Abbreviations: HF- heart failure; ACEI – angiotensin converting enzyme inhibitors; ARB – angiotensin receptor blocker; CCB – calcium channel blocker; CVD – cardiovascular disease; CVA – cerebrovascular accident; PAD – peripheral arterial disease; SBP – systolic blood pressure; DBP – diastolic blood pressure; BMI – body mass index; BNP – brain natriuretic peptide; BUN – blood urea nitrogen; SD – standard deviation.
Due to the large sample size traditional comparisons were all statistically significant, and we hence determined significance based on biologically relevant differences.